Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The anaphase promoting complex subunit 13 pseudogene (ENSG00000270719) is a non-protein-coding genomic locus believed to have originated from the ANAPC13 gene, a component of the anaphase-promoting complex/cyclosome (APC/C) involved in cell cycle regulation. As a pseudogene, it does not encode a functional protein and is not known to have direct biological function. Some pseudogenes can regulate the expression of their parental genes, but no such function has been confirmed for this pseudogene. Clinical, therapeutic, or biomarker relevance has not been established for this locus[5][8][2]. This entry refers specifically to a pseudogene and not a functional drug target or receptor. Information about disease relevance, function, or molecular classification should not be confused with the protein-coding gene ANAPC13; the pseudogene status makes it irrelevant for conventional drug target lists and structured annotation as a therapeutic target[5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anaphase promoting complex subunit 13 pseudogene.